In his weekly clinical update, Dr. Griffin discusses completeness and spin of medRxiv preprints and associated published abstracts of COVID-19 randomized clinical trials, lessons learned from a COVID-19 dog screening pilot in California K-12 schools, SARS-CoV-2 reinfection and severity of the disease, effectiveness of COVID-19 bivalent vaccine, Molnupiravir and risk of post-acute sequelae of COVID-19, risk of new-onset long Covid following reinfection with SARS-CoV-2, low vitamin D levels associated with long COVID syndrome in COVID-19 survivors, and clinical experience with the α2A-adrenoceptor agonist, guanfacine, and N-acetylcysteine for the treatment of cognitive deficits in “Long-COVID19”.
Click arrow to play Download TWiV 1002 (27 MB .mp3, 44 min)
Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email
Become a patron of TWiV!
Links for this episode
- Completeness and spin of medRxiv preprint and published abstracts of COVID-19 randomized clinical trials (JAMA) 4:11
- Lessons learned from a COVID-19 dog screening pilot (JAMA) 5:57
- SARS-CoV-2 reinfection and severity of the disease (Viruses) 8:09
- Effectiveness of COVID-19 bivalent vaccine (medRxiv) 10:55
- Molnupiravir and risk of post-acute sequelae of COVID-19 (BMJ) 21:23
- Risk of new-onset long Covid following reinfection with SARS-CoV-2 (medRxiv) 25:15
- Low vitamin D levels are associated with Long COVID in COVID-19 survivors (JCEM) 26:10
- Clinical experience with the α2A-adrenoceptor agonist, guanfacine, and N-acetylcysteine for treatment of Long-COVID19 (NIH) 28:31
- Contribute to our ASTMH fundraiser at PWB 31:26
- Letters read on TWiV 1002 32:13
- Timestamps by Jolene. Thanks!
Intro music is by Ronald Jenkees
Send your questions for Dr. Griffin to daniel@microbe.tv
Leave a Reply